News / DB Schenker eyes expanded footprint in Americas via land transport

first_img© Mohamed Ahmed Soliman “We are developing our land product everywhere now,” said Mr Gilbert, adding that the push was “from Argentina to Canada”.This arena offers a large opportunity for a company like Schenker, which has strong know-how built on its extensive presence in the sector in Europe, said chairman Jochen Thewes.Schenker took a decisive step into the North American market at the end of 2005 when it acquired BAX Global for $1.1bn, but it later divested itself of the US logistics firm’s freighter fleet and cut down on the surface network.Mr Thewes said the air network – comprising a fleet of ageing freighters in a high oil price environment – was difficult to maintain. Today, he would prefer that the company had kept more of the domestic land activity. “We have some building to do,” he said.This does not mean Schenker is looking to set up a trucking network or acquire assets. The strategy rests on the non-asset side, providing transport brokerage and assorted services.The company also wants to hone and leverage expertise in some verticals, such as aerospace and automotive, added Mr Gilbert.Schenker’s land activities in the NAFTA region will be affected by the outcome of negotiations about the trade pact. However, airline and forwarder executives have reported that the issue hardly figures in talks with their clients, who appear preoccupied with the growth in international flows these days. For his part, Mr Thewes sees no impact from the uncertainty over the future of NAFTA.“Generally speaking, our customers have cargo that needs to be moved due to customer demand, and our customers are not re-scheduling based on political speculation,” he said.He added that some NAFTA flows were linked to intercontinental traffic.In the US, one area of growth for Schenker has been an increased use of free trade zones (FTZs). Recently it activated an FTZ at Los Angeles Airport, which has since been used by some clients from the electronics and fashion sectors, and last year the company set up a high-security warehouse with FTZ designation in New York that serves some high-profile brands in luxury fashion.“Our growth in free trade zones is driven by customer request,” said Mr Gilbert. “Currently we operate FTZs in LA and Chicago (O’Hare airport), and we are looking to expand in other gateways across the Americas.” DB Schenker is shifting its focus in the Americas – but not changing course: the multinational logistics firm is looking to build up its presence in the land transport arena.“Our core business in the Americas – air, sea and contract logistics – is going nicely; we are having two-digit growth there,” said Philippe Gilbert, regional CEO of DB Schenker Americas.“We look forward to developing our land business.”This includes domestic and cross-border activities, as well as clearance. While the NAFTA region is the most developed in terms of land transport flows, Schenker’s focus reaches all the way to the southern end of the hemisphere.center_img By Ian Putzger 20/11/2017last_img read more

Pulitzer Prize-winning doctor wades into biotech with cancer startup

first_img Dr. Siddhartha Mukherjee developed the core technology behind Vor BioPharma. Evan Agostini/Invision/AP Damian Garde But Vor, launched on Monday by Boston startup factory PureTech Health, is years behind. Its CAR-T candidates are still being studied on mice, and the company has no timeline for clinical trials. Furthermore, Vor’s bedrock science comes from a surprising source: Dr. Siddhartha Mukherjee, a Columbia University physician-scientist who won the Pulitzer Prize in 2011 for his book “The Emperor of All Maladies: A Biography of Cancer.”As oncologists go, Mukherjee is about as famous as it gets. His last book was adapted into a PBS miniseries by the awarding-winning documentarian Ken Burns, and his latest one, “The Gene: An Intimate History,” has been well-received.But his resume as a drug hunter is comparatively light. Though Mukherjee has long worked in blood cancer, and he has a couple dozen journal articles to his name, his research has never crossed over into drug development. He has never published an academic paper on CAR-T, and his only listed patent is unrelated to the field. BusinessPulitzer Prize-winning doctor wades into biotech with cancer startup Vor is working on technology that uses the immune system to fight cancer. The process entails removing patients’ disease-fighting T cells and reengineering them to home in on the telltale signs of tumors. The resulting products, called CAR-T cells, are then injected back into the body as newly armed tumor-killers. About the Author Reprints @damiangarde Announcing the birth of a new biotech company tends to follow a well-worn path: There’s a breathless press release explaining the technology, a list of moneyed investors buying into it, and a sizable dollar figure thrown in for gravitas.But a new oncology upstart is turning heads in the industry with none of those things. Instead, Vor BioPharma is getting off the ground with few details on its unproven approach to cancer and enlisting the aid of a scientist whose big prize is named for Joseph Pulitzer, not Alfred Nobel.What’s more, the Boston-based company is wading into a field crowded with competition, where “if they’re going to go me-too, they’re going to lose,” said Eric Schmidt, a biotech analyst at Cowen Group.advertisement Newsletters Sign up for Daily Recap A roundup of STAT’s top stories of the day. Related: By Damian Garde May 9, 2016 Reprints Mukherjee isn’t the only scientific mind at work within Vor, though. The company’s Acting Chief Scientific Officer is Joseph Bolen, who filled the same role for 14 years at Millennium Pharmaceuticals, where he developed the blockbuster cancer drug Velcade. Joining him as scientific founders are Stanford University radiologist Dr. Sanjiv Sam Gambhir, New York University immunologist Dr. Dan Littman, and Harvard University stem cell biologist Derrick Rossi, all of whom have advised academic spinoffs in the past.What brought them all together, Rossi said, was the promise of Mukherjee’s CAR-T discoveries. And Rossi believes Vor’s work will eventually clear up any skepticism around Mukherjee’s bona fides in the field.“What’s published in a lab and what’s not published in a lab — the actual work going on — are two completely different things,” Rossi told STAT. “There’s a lot of really exciting science coming that hasn’t seen the light of publication yet.”center_img [email protected] Watch: Turning your cancer against itself Privacy Policy National Biotech Reporter Damian covers biotech, is a co-writer of The Readout newsletter, and a co-host of “The Readout LOUD” podcast. Tags cancerimmunotherapypharmaceutical industry CAR-T isn’t terribly new. Novartis, with help from the University of Pennsylvania, has demonstrated stellar clinical results with the technology in lymphoma and plans to submit its lead therapy for marketing approval next year. And behind the Swiss drug giant are a group of smaller US firms including Juno Therapeutics and Kite Pharma, all of which have successfully treated human tumors with their technology and are moving toward regulatory filings.advertisement Leave this field empty if you’re human: One thing Vor is disclosing: The young company is looking for areas where its bigger and better-established forbears haven’t succeeded. To date, the majority of CAR-T projects have focused on leukemias and lymphomas that stem from white blood cells called B cells, but according to PureTech associate Aleks Radovic-Moreno, Vor is staying out of that field altogether, training its efforts on cancers outside the realm of B cells.It’s early days for Vor, and it will take years to determine whether the company can eventually compete with the likes of Novartis, Juno, and Kite. But cancer is “a massive opportunity with tons of unmet need,” Cowen’s Schmidt said, and there’s plenty of room for new ideas. “Just because there are other well-funded CAR-T companies ahead of them doesn’t mean they couldn’t have success.”Kendall Squared brings you dispatches from the world’s epicenter for biotechnology and drug discovery. Please enter a valid email address. Related: The newest cancer therapies don’t work on everyone. Now, doctors have a clue why last_img read more

As the world’s top blood experts gather, 5 key questions to watch

first_imgBiotechAs the world’s top blood experts gather, 5 key questions to watch Experimental cancer therapy holds great promise — but at great cost Meghana Keshavan Privacy Policy SAN DIEGO — The world’s experts on all things blood will convene here starting Friday to discuss the latest advances in treating disorders ranging from hemophilia to sickle cell anemia to cancers like leukemia and lymphoma.Academics will share their latest research. So will scientists from biotech startups and global drug companies. Here, five questions we’ll be seeking answers to at the American Society of Hematology meeting, which runs through Tuesday.1. How safe are the latest cancer immunotherapies?There will be a lot of buzz about CAR-T immunotherapy, and for good reason. It’s been a rough year for the intricate cellular science, which involves extracting cancer patients’ own immune cells and engineering them to attack their tumors.advertisement Two other startups working on CAR-T will also give presentations. Bluebird Bio will share early data from a clinical trial that has gone very well so far: Tumors shrank in the six multiple myeloma patients who received a high dose of Bluebird’s CAR-T therapy, and two of them had no traces of cancer after several months. It’s still early in the trial, but cancer doctors will be eager to hear more.At one of the last sessions of the conference, we’ll hear from Kite Pharmaceuticals, which is widely expected to be the first to get a CAR-T therapy to market. Expectations are running high for Kite’s pivotal Phase 2 ZUMA-1 study, which is testing a CAR-T therapy in lymphoma patients. We’ll see the data on Tuesday.2. Are we finally making progress against sickle cell?Sickle cell anemia — which can cause intense pain, infections, and even organ failure — has been stubbornly hard to treat for decades.We might finally get some good news this weekend. Juno Therapeutics, one of the leaders in the field, stunned the research community with news that five patients died due to side effects from a CAR-T therapy it developed with an experimental drug called JCAR015. Clinical trials for that drug are now on hold. Selexys Pharma, a small biotech based in Oklahoma, will be presenting the results of a trial of a drug to treat sickle cell. It uses an antibody called SelG1 to try to cut down on episodes of “sickle cell-related pain crises,” in which the malformed blood cells obstruct circulation in blood vessels.One hint that the results will be positive: Selexys was recently acquired by Novartis in a $665 million deal.3. Can we do transfusions with artificial blood cells?Early stage research led by Washington University in St. Louis suggests that, one day, we may not have to go through the hardship of transporting blood to hard-to-reach locations, such as battlefields.The concept behind these synthetic blood cells is simple: just add water. In theory, they’re then ready to transfuse into a patient.The product, called ErythroMer, is still in very early, preclinical stages — but it’ll be interesting to hear more. A solid proof-of-concept could have some intriguing applications.4. Are we entering a new era for lymphoma care?A trio of Phase 3 studies seems to indicate that the standard of care to treat lymphoma could be shaken up.Next-generation biologic drugs, coupled with chemotherapy, are helping some cancer patients live longer without their tumors growing substantially.One of the drugs up for discussion is from Genentech. Marketed as Gazyva, it seems to be more effective in treating follicular lymphoma than Rituxan — another widely used Genentech drug. NewslettersSign up for The Readout Your daily guide to what’s happening in biotech. We’ve known for 50 years what causes sickle cell disease. Where’s the cure? Related: Leave this field empty if you’re human: 5. Can we stop the body from rejecting cell therapies?As we hurtle toward the era of cell therapies, such as CAR-T, one key question is how to scale up such highly personalized treatments — and how to do it in a cost effective way.Right now, cell therapies usually involve extracting a patient’s own cells and turning them into a biologic drug to infuse back into the patient. That’s called an autologous cell transplant. Some companies are trying instead to develop a one-size-fits-all cell therapy, called an allogeneic transplant. In theory, such a treatment would be quicker and cheaper to develop than one customized to each individual patient’s cells.But it’s been a hard road, because the immune system tends to attack any foreign body — like an unfamiliar cell — in what’s known as “graft vs. host disease.” (That’s why patients who receive organ transplants have to take powerful immune system suppressants to ward away organ rejection.)At the ASH conference, we’ll get a peek at several intriguing new approaches to treat graft vs. host disease. Specifically, it looks like the cancer drug ibrutinib shows promise in preventing the immune system from flaring up against allogeneic transplants. We’ll be eager to see more data.center_img About the Author Reprints Juno executives will give more details both on the JCAR017 trial and its investigational work on another therapy, JCAR018, which has not experienced the same problems. They’ll seek to settle swirling concerns from investors, patients, and physicians about the safety of CAR-T — which has great promise, but also holds serious risks.advertisement Biotech Correspondent Meghana covers biotech and contributes to The Readout newsletter. By Meghana Keshavan Dec. 2, 2016 Reprints Please enter a valid email address. Red blood cells. Annie Cavanagh/Wellcome Images Tags biotechnologycancerdrug developmentresearch [email protected] @megkesh Related:last_img read more

Winner announced in Racket Hall Competition

first_img Community Winner announced in Racket Hall Competition New Arles road opens but disquiet over who was invited to official opening RELATED ARTICLESMORE FROM AUTHOR Previous articleIn Pictures: All the best pictures from Day 2 of Cumann na mBunscol football finalsNext articleIrish Wheelchair Association Portlaoise is looking for help with national campaign LaoisToday Reporter Twitter By LaoisToday Reporter – 25th October 2018 The Racket Hall in Roscrea is one of the best known hotels in the region.Located on the outskirts of the Tipperary town, on the busy N7 road and right beside Roscrea Golf Club, it has 40 bedrooms, two restaurants and caters for everything from weddings to coferences.The newly refurbished Ballroom is a magnificent setting for both family celebrations, concerts and business conferences.To celebrate their Wedding Showcase which was on Sunday last we teamed up with Racket Hall Hotel to give away a Romantic Overnight Stay for two in one of their luxurious Suites with breakfast the following morning.All you needed to do was like and share the post, like the LaoisToday page and tag the person you will bring with you!And the winner of the competition is Jackie Whelan from Abbeyleix. Congratulations Jackie!! We hope you enjoy your stay.Keep an eye on our Facebook page for another great giveaway with the Racket Hall in the coming days.SEE ALSO – Check out the dedicated jobs section on LaoisToday Facebook Charlie Flanagan on Electric Picnic: ‘I’d ask organisers to consult with community leaders’ Pinterest Laois secondary school announces scholarship winners for new academic year WhatsApp WhatsApp TAGSRacket Hall Roscrea Community Twitter Pinterest Council Home News Winner announced in Racket Hall Competition News Facebooklast_img read more

Coronavirus Daily Noticeboard– Monday, March 30, 2020

first_imgKelton Cleaners open for business in Lyster Square in PortlaoiseLaundrettes are among the businesses that permitted to stay open during the Coronavirus restrictions – and Kelton Cleaners in Lyster Square in Portlaoise is open to meet the needs of its customers at this time.Located opposite the libary in Lyster Square, Kelton Cleaners is open Monday to Saturday, from 12noon to 4pm offering:Dry CleaningWash and DryIroning ServiceThe cleaners in Mountmellick and on the Dublin Road owned by Stapo Browne are closed at this time. They will open again on Tuesday, April 14.Sorry for any inconvenience caused.Contact 087 2651930 for collection and delivery. Facebook By Steven Miller – 30th March 2020 Tullamore Show cancelledDay by day more events are being cancelled.Today’s big announcement concerns the Tullamore Show, the hugely popular and well-attended one-day agricultural show in Tullamore in August.Rodney Cox, the chairperson of the Tullamore Show, confirmed to AgriLand that the show – originally set for August 9 this year – is cancelled and that the 2021 show will take place on August 8 next year.Cox explained to this publication that one of the key reasons that the committee made the decision to cancel the show was to be “respectful to the other shows”.“It wouldn’t be fair for us to pick a date later in the year and clash with another show. We’re all in this together. We enjoy the relationship with the other shows.”You can read the full story on Agriland here. Ryan Tubridy tests positive for CoronavirusRTÉ presenter Ryran Tubridy has tested positive for coronavirus, RTÉ has said.Tubridy has been self-isolating after symptoms of a persistent cough; he hasn’t presented his RTÉ Radio programme or the Late Late Show since he had these symptoms.Ryan Tubridy said; “Like so many other people in Ireland, I tested positive but I was in the very fortunate position to have a very unintrusive experience, which I now have come to the end of.Private hospitals to be leased for duration of Coronavirus crisisThe Taoiseach has announced that private hospitals will be leased for use as public hospitals for the duration of the Covid-19 outbreak in Ireland, treating both patients who have the virus and those with other non-related illnesses.Taoiseach Leo Varadkar and Health Minister Simon Harris today announced a new public private partnership between the HSE and the Private Hospitals’ Association.The arrangement will be in place for an initial three-month period, with an option to extend it after that on a mutually-agreed basis.The private hospital sector, which is made up of 19 hospitals, has an estimated bed capacity of 1,900 inpatient beds, 600 day beds as well as 47 ICU and 54 HDU beds. Home News Community Coronavirus Daily Noticeboard– Monday, March 30, 2020 NewsCommunity WhatsApp Twitter Previous articleBREAKING: 295 new cases of Coronavirus in Ireland and eight more deathsNext articleNolans Locksmiths announce details of 24/7 call out service during Coronavirus pandemic Steven Millerhttp://www.laoistoday.ieSteven Miller is owner and managing editor of LaoisToday.ie. From Laois, Steven studied Journalism in DCU and has 14 years experience in the media, almost 10 of those in an editorial role. Husband of Emily, father of William and Lillian, he’s happiest when he’s telling stories or kicking a point. News Telfords in Portlaoise and Mountrath: We will supply goods for EMERGENCY PURPOSES ONLYFollowing the Government announcement on Friday evening last both Portlaoise and Mountrath are now closed with the exception of delivery for EMERGENCY PURPOSES ONLY. We will continue to supply goods that are for EMERGENCY PURPOSES ONLY!If you need an emergency delivery, please TEXT the details of 087 9448265 or email [email protected] or order online at www.telfordselectric.ie.A member of staff will come back to you as soon as possible.See more details here. Worth a read – Coranavirus cluster in US choirThe LA Times have a fascinating – and worrying piece – about a choir in Washington whose rehearsal on March 10 was attended by 60 members.Less than three weeks later 45 of them have been diagnosed with Coronavirus, three have been hospitalised and two are dead.You can read the full piece here on the LA Times website. SEE ALSO – Coronavirus Daily Update – Sunday, March 29, 2020 In Pictures: Portlaoise Hospital triple number of ICU beds as Coronavirus pandemic continuesPortlaoise Hospital has trebled the amount of beds it has in their Intensive Care Unit as staff and management brace themselves to deliver critical care to patients who have been hospitalised with Coronavirus.Sandra McCarthy, the Director of Nursing in Portlaoise General Hospital, explained on social media last week that staff have vacated the staff room and offices to create additional isolation facilities.HSE sources confirmed to LaoisToday that prior to this, Portlaoise had two ICU beds.However, they have now increased capacity to six as they brace themselves for the worst of this pandemic.Read the full story here RELATED ARTICLESMORE FROM AUTHOR WhatsApp Studying during Coronavirus: Portlaoise CBS on prepping for state examsIn the first part of our series chatting to students who are trying to prepare for their state exams amid this uncertain period, we chat to Portlaoise CBS student and Stradbally native Eamonn Delaney.You can read the piece in full here. Dunamase CollegeLaois school launch online well-being week for studentsDunamase College, a multidenominational, bilingual secondary school in Portlaoise, is launching an online well-being week from today to support students who cannot come to school while the country comes together to tackle the COVID-19 pandemic.In Dunamase College, which has an Irish language stream and an English language stream, learning through technology is something they do everyday.You can read the piece in full here.  295 new cases; 8 more deathsA total 295 of new cases of Coronavirus have been diagnosed in Ireland today.This is an increase on the 2,615 cases from yesterday and takes the overall total to 2,910. Twitter Electric Picnic Facebook Electric Picnic Bizarre situation as Ben Brennan breaks up Fianna Fáil-Fine Gael arrangement to take Graiguecullen-Portarlington vice-chair role Coronavirus Daily Noticeboard– Monday, March 30, 2020 Pinterest Pinterest Japanese figures?A spike in Tokyo’s coronavirus cases following the postponement of the Olympics has raised questions as to whether Japan purposely understated the extent of the outbreak in the hope the games would run as scheduled.Meanwhile, the Olympics will take place between 23 July and 8 August next year.The International Olympic Committee confirmed the news this afternoon, which followed a meeting of the Tokyo 2020 organising committee.The Paralympic Games, meanwhile, will take place from 24 August to 5 September 2021.Irish Open in Mount Juliet postponedThe Irish Open has become the latest sporting event to be postponed due to the spread of Coronavirus.The European Tour announced this afternoon that the Dubai Duty-sponsored event has been deferred after being scheduled to take place at Mount Juliet Estate in Kilkenny from 28-31 May with 2010 US Open champion Graeme McDowell as host.A decision on when to reschedule the tournament is yet to be made with the European Tour stating they will wait until they ‘have clarity on the global situation’ in relation to postponed tournaments.Grealish apologises after crashing car during lockdownAston Villa captain Jack Grealish has issued a public apology following an incident that saw him break the coronavirus lockdown in Britain before being involved in a minor car crash.The English international, who played at underage level for Ireland, crashed his car on Sunday morning.According to the Press Association, West Midlands Police said they were called just before 10am on Sunday to the Dickens Heath area of Solihull, where the two parked cars suffered minor damage.The force said the driver left his details with a member of the public before leaving on foot.The incident came less than 24 hours after Grealish urged people to stay in doors during the lockdown.Wife in the boot; windows in the carA driver in the UK defied the Coronavirus lockdown to pick up £15 windows with his wife in the boot of his car.The man, who had bought the windows on eBay, was stopped by police on the M6 in Cheshire on Sunday after collecting his purchase in Salford.Police said his wife had to sit in the boot as she “could not fit in the vehicle” for the return journey to Coventry.North West Motorway Police issued the man with a traffic offence report.You can read the full story on the BBC website here. Laois Councillor ‘amazed’ at Electric Picnic decision to apply for later date for 2021 festival Due to the sheer volume of notices in relation to the Coronavirus, we can’t do an individual story on each one.So we are compiling a daily bulletin that includes updates from various community groups, clubs and organisations.The noticeboard will be published on LaoisToday and shared on our social media every evening. While now 54 people have died from the disease – an increase of eight from yesterday.You can read the full detail from Alan Hartnett’s daily update here.  TAGSCoronavirusCoronavirus Daily Noticeboard Electric Picnic organisers release statement following confirmation of new festival datelast_img read more

U-20 players should play at their own age grade first, says Laois GAA secretary

first_img Twitter Previous articleKilleshin appoint new manager for 2021 seasonNext articleFr Paddy: The life of faith also teaches us how to wait Steven Millerhttp://www.laoistoday.ieSteven Miller is owner and managing editor of LaoisToday.ie. From Laois, Steven studied Journalism in DCU and has 14 years experience in the media, almost 10 of those in an editorial role. Husband of Emily, father of William and Lillian, he’s happiest when he’s telling stories or kicking a point. Twitter Facebook By Steven Miller – 5th December 2020 Electric Picnic WhatsApp U-20 players should play at their own age grade first, says Laois GAA secretary Electric Picnic apply to Laois County Council for new date for this year’s festival Pinterest Photo: Paul Dargan Laois GAA secretary Niall Handy has said that county underage players should play at their own grade first and that should be adopted as policy going forward.Writing in his annual report to this year’s Laois GAA convention, Niall Handy references the controversy earlier this year when senior footballers Mark Barry and Sean O’Flynn were initially prevented by the senior management from playing in the U-20 championship when games were on the same weekend.The two players did eventually play with the U-20s but Handy believes that the County Board should adopt a policy where players in that position should play with their own age grade first.“One issue that must be addressed and I believe will be in a form of motion before next Congress, will be where a player who participates in an Allianz League game, will then become ineligible to play for his U-20 team in that year’s competition,” he writes.“It was an issue that happened internally with some players involved with both senior and U-20 panels this year and no doubt undue pressure was exerted on these players when the decision came to choose a particular grade.“Whilst I wouldn’t be rushing to incorporate into rule, as the situation may differ fromcounty to county based on population, my opinion is quite clear in that they should play attheir own grade first, and I believe it should be a County Executive policy decision.”While the U-20 grade has had different formats and been played at different times of the year since it was changed from U-21 in 2018, Handy says that it is likely to be reduced to U-19 in the future.“I do envisage recommendations down the line for it to revert back to an U-19 competition, in line with proposals arising from the Talent Academy & Player Development Review Report, which was chaired by our own Michael Dempsey and released earlier this year.”Referencing this year’s U-20 team that were beaten in the Leinster final by Dublin he said “the difference in pace and conditioning between the two teams was a little frightening”.Manager Eddie Kinsella is back for a second year in the role and a provisional panel have been working to a strength and conditioning programme in recent weeks under Pauraic McEvoy and Tom Hargroves.SEE ALSO – Laois minor footballers and U-20 hurlers get green light to resume before Christmas Electric Picnic WhatsApp Home Sport GAA U-20 players should play at their own age grade first, says Laois… SportGAAGaelic Football RELATED ARTICLESMORE FROM AUTHOR Laois Councillor ‘amazed’ at Electric Picnic decision to apply for later date for 2021 festival TAGSLaois GAANiall Handy Electric Picnic organisers release statement following confirmation of new festival date Facebook Electric Picnic Pinterestlast_img read more

Passive investing for pot coming to TSX

first_img Share this article and your comments with peers on social media Big Marijuana Bud on Indoor Plant Under Lights at Cannabis Farm openrangestock/123RF James Langton HSBC debuts stock-picking AI index Related news New indexes align with Paris Agreement targets A couple of new cannabis-focused indexes are coming to Toronto Stock Exchange’s (TSX) data feeds.The TSX announced that three new indexes are going to be released on the TSX Real-Time Index (TX1) feed in mid to late November. Two of the new indexes are focused on the cannabis sector. Facebook LinkedIn Twitter Keywords Cannabis,  IndexesCompanies Toronto Stock Exchange The S&P/TSX Cannabis Index will track the performance of cannabis companies that are trading on either the TSX or the TSX Venture Exchange (TSXV). The ​S&P/MX International Cannabis Index will track companies that are trading on the New York Stock Exchange (NYSE) or NASDAQ, along with the TSX and the TSXV.The third new index, the S&P/TSX SmallCap Select Index, includes companies that are part of the S&P/TSX SmallCap Index that “have a demonstrated track record of generating positive earnings.”The exchange says that the indexes’ methodologies will be disclosed closer to their launch. Bringing ethnic diversity to indexinglast_img read more

Unitholders approve changes to NEI funds

first_imgGreen figgy bank with calculator flynt/123RF Share this article and your comments with peers on social media Toronto-based Northwest & Ethical Investments L.P. (NEI) has announced that unitholders have approved changes to two NEI funds.Changes to NEI Balanced RS FundThe NEI Balanced RS Fund is being rebranded as the NEI Global Sustainable Balanced Fund. It will move from investing in a mix of Canadian and U.S. securities to focusing on “a globally diversified portfolio of equity and fixed income securities which fit within the fund’s definition of responsible investing,” according to a release.The fund will be sub-advised by Impax Asset Management, replacing Guardian Capital LP and QV Investors Inc. Its benchmark indexes are also changing, and its investment strategies will be updated to fulfill its new investment objectives.Changes to NEI Jantzi Social Index FundThe NEI Jantzi Social Index Fund is being rebranded the NEI ESG Canadian Enhanced Index Fund.It will move from investing in equity and equity-related securities of companies in Canada to “tracking the performance of a Canadian equity index which is focused on companies with an enhanced environmental, social and governance profile,” the release said.The fund’s benchmark index will change from the S&P/TSX 60 TR to the Solactive Canada Broad Market Index. Its investment strategies will be updated to fulfill its new investment objectives.Changes coming in AprilThe changes outlined above will take effect on or about April 6, according to the release. Management fees have been reduced for multiple series of both funds. For further details, see NEI’s release.NEI has also announced that the benchmark index for the NEI Tactical Yield Portfolio will change from the Russell 3000 Value TR Index (hedged to CAD) to the Russell 3000 Value TR Index (CAD) on or about Jan. 28. ESG interest on the rise, but so is fear of greenwashing Purpose looks to fill retirement income gap with longevity fund Keywords Responsible investing,  Mutual funds,  MERs and management fees,  Investment strategies,  Investment funds,  Impact investingCompanies Northwest & Ethical Investments LP Related news IG Wealth amends product shelf IE Staff Facebook LinkedIn Twitterlast_img read more

Spatial Data Division made Significant Strides Last Fiscal Year

first_imgSpatial Data Division made Significant Strides Last Fiscal Year UncategorizedJuly 4, 2007 Advertisements RelatedSpatial Data Division made Significant Strides Last Fiscal Year FacebookTwitterWhatsAppEmail The Spatial Data Management Division in the Ministry of Agriculture and Lands made several significant achievements during the last fiscal year, chief of which was the establishment of a national portal to access geospatial data.“This geospatial web portal will seamlessly integrate information on geology, topography and socio-economic conditions locally and hence facilitate the development of disaster management initiatives and sustainable planning activities,” said State Minister in the Ministry, Victor Cummings.The State Minister, who was making his contribution to the 2007/08 Sectoral Debate in the House of Representatives yesterday (July 3), informed that base data on Jamaica such as parish boundaries, road network, rivers, schools, hospitals and fire stations are available via the portal.“There are also emergency management data sets inclusive of emergency shelters, hurricane tracks from 1950 to 2005, and high risk flood-prone areas, among others. The national benefits over the long-term will be noticeable with improvements in the development approval process as information, which is needed to make decisions, will now be readily available and accessible,” he pointed out further.Another achievement of the division was the development of metadata guidelines, which were approved by Cabinet in July 2006. Metadata is “data about data” and these guidelines will ensure the maintenance of the government’s investment in spatial data, explained Mr. Cummings.“This is fundamental to the national spatial data infrastructure and the management of data resources, data recovery, re-use and data sharing among users,” he told the House.In addition, through the Ministry of Agriculture and Lands and the Land Information Council of Jamaica (LICJ), 80 persons from both the public and private sectors were trained at the LICJ Geoinformatics Lab during 2006.The Minister also informed that the Ministry partnered with the Caribbean Institute of Technology to develop the Certificate in Geographic Information programme. “This course was developed in order to offer increased career opportunities to young Jamaicans in a new exciting and growing technological field,” Mr. Cummings said.The Spatial Management Division is responsible for coordinating the development, implementation, maintenance, and management of a national networked Geographic Information System, among land and land related agencies.center_img RelatedSpatial Data Division made Significant Strides Last Fiscal Year RelatedSpatial Data Division made Significant Strides Last Fiscal Yearlast_img read more

PM Golding Responds to Telecommunications Queries

first_imgRelatedPM Golding Responds to Telecommunications Queries PM Golding Responds to Telecommunications Queries Office of the Prime MinisterApril 15, 2009 RelatedPM Golding Responds to Telecommunications Queries FacebookTwitterWhatsAppEmail The sixty schools remaining to be equipped with Information and Communications Technology (ICT) facilities will be online by August.Prime Minister Bruce Golding, made this report during the meeting of the Standing Finance Committee in Parliament yesterday (April 14).The schools will join 120 other institutions that were outfitted with support from the Universal Access Fund, which has collected more than $5 billion from telecom providers.The average level of outfitting for each school is: 56 desktops, 22 laptops and 5 to ten projectors. The schools have LAN Internet connectivity, but a submission is on its way to Cabinet to ask for permission to upgrade to broadband.The Prime Minister noted that the Fund would eventually address public libraries and Post Offices.center_img RelatedPM Golding Responds to Telecommunications Queries Advertisementslast_img read more